Wednesday, September 23 2020


IBM, Five9 to provide evidence-backed cancer treatment AI

Update: December, 13/2017 - 15:46
The signing ceremony between IBM and Five9 to implement IBM Watson for Oncology in Việt Nam. - Photo
Viet Nam News

HÀ NỘI — IBM and Five9 on Tuesday announced their partnership to implement IBM Watson for Oncology – the first artificial intelligence (AI)-driven oncology clinical decision support system that helps doctors advance cancer care for patients  in Việt Nam.

Phú Thọ Hospital will be the first in Việt Nam to adopt IBM Watson for Oncology.

According to Nguyễn Trọng Huấn, director of software provider Five9, IBM Watson for Oncology provides clinicians with confidence-ranked treatment options and supporting evidence to help them make treatment decisions for their patients.

With IBM Watson for Oncology, trained by New York-based Memorial Sloan Kettering Cancer Centre, one of the world’s leading cancer centres, physicians can quickly identify key information related to the patient’s medical record, find relevant evidence and explore treatment options.

Huấn said profits from implementing IBM Watson for Oncology would be used to support patients using this system.

According to the company, IBM Watson for Oncology is being used by some 80 hospitals in 11 countries.

It is now available to assist clinicians on breast, lung, colon and rectal, as well as gastric, ovarian, cervical and prostate cancers.

Nguyễn Viết Tiến, deputy minister of health, said IBM Watson for Oncology marked a new step in applying information technology in cancer treatment in Việt Nam to enhance quality of healthcare services. — VNS




Send Us Your Comments:

See also: